These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11245297)

  • 21. Sequential therapy for Helicobacter pylori: time to consider making the switch?
    Vakil N; Vaira D
    JAMA; 2008 Sep; 300(11):1346-7. PubMed ID: 18799448
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance in Helicobacter pylori.
    Teare L; Peters T; Saverymuttu S; Owen R; Tiwari I
    Lancet; 1999 Jan; 353(9148):242. PubMed ID: 9923909
    [No Abstract]   [Full Text] [Related]  

  • 24. [First line eradication treatment of Helicobacter pylori in 2019].
    Gressot P; Frossard JL; Grosgurin O; Marti C
    Rev Med Suisse; 2019 Oct; 15(667):1854-1858. PubMed ID: 31617972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia.
    Parasakthi N; Goh KL
    Am J Gastroenterol; 1995 Mar; 90(3):519. PubMed ID: 7872306
    [No Abstract]   [Full Text] [Related]  

  • 26. Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases.
    Gomollón F; Ducóns JA; Ferrero M; García Cabezudo J; Guirao R; Simón MA; Montoro M
    Helicobacter; 1999 Dec; 4(4):222-5. PubMed ID: 10597390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-helicobacter regimens.
    Harris A; Misiewicz JJ
    Lancet; 1996 Apr; 347(9009):1193-4. PubMed ID: 8609799
    [No Abstract]   [Full Text] [Related]  

  • 28. [Helicobacter pylori resistance: who needs what treatment?].
    Courillon-Mallet A
    Presse Med; 2006 Apr; 35(4 Pt 2):657-62. PubMed ID: 16614611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choosing triple therapy for Helicobacter pylori in children: antimicrobial resistance testing of first gastric biopsy culture may predict outcome.
    Kalach N; Benhamou PH; Dupont C; Raymond J
    J Pediatr Gastroenterol Nutr; 2001 Feb; 32(2):225-6. PubMed ID: 11321403
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.
    Murakami K; Fujioka T; Okimoto T; Sato R; Kodama M; Nasu M
    Int J Antimicrob Agents; 2002 Jan; 19(1):67-70. PubMed ID: 11814770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The search for optimal Helicobacter pylori eradication regimen: a mid 1997 update.
    Deltenre M; De Bruyne L; Ntounda R; De Koster E; Lamy V
    Acta Gastroenterol Belg; 1998; 61(3):344-7. PubMed ID: 9795469
    [No Abstract]   [Full Text] [Related]  

  • 32. Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
    Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
    Aliment Pharmacol Ther; 2000 Aug; 14(8):991-9. PubMed ID: 10930892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
    Nagahara A; Sato N
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():421-5. PubMed ID: 16363572
    [No Abstract]   [Full Text] [Related]  

  • 34. Sofalcone for treatment of Helicobacter pylori infection.
    Fujioka T; Murakami K; Kubota T; Kodama R; Honda S; Nasu M
    J Gastroenterol; 1996 Nov; 31 Suppl 9():56-8. PubMed ID: 8959521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting Helicobacter pylori eradication: how to teach an old dog new tricks!
    Zullo A; De Francesco V; Hassan C
    J Clin Gastroenterol; 2012 Apr; 46(4):259-61. PubMed ID: 22395061
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of treatment of Helicobacter pylori on the normal gastrointestinal microflora.
    Adamsson I; Edlund C; Nord CE
    Clin Microbiol Infect; 2000 Apr; 6(4):175-7. PubMed ID: 11168104
    [No Abstract]   [Full Text] [Related]  

  • 37. [Helicobacter pylori: what schemes of eradication are essential today?].
    Maev IV; Samsonov AA; Golubev NN
    Ter Arkh; 2011; 83(8):41-4. PubMed ID: 21961331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.
    Dos Santos AA; Carvalho AA
    World J Gastroenterol; 2015 Jan; 21(1):139-54. PubMed ID: 25574087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antimicrobial sensitivity of Helicobacter pyloriø].
    López-Brea M
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():32-5. PubMed ID: 7914433
    [No Abstract]   [Full Text] [Related]  

  • 40. Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance.
    Tong YF; Lv J; Ying LY; Xu F; Qin B; Chen MT; Meng F; Tu MY; Yang NM; Li YM; Zhang JZ
    World J Gastroenterol; 2015 Dec; 21(46):13073-9. PubMed ID: 26672777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.